Tag: Patrick Loofbourrow
Six firms assist on AstraZeneca’s USD1.2bn Gracell purchase
Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion
Structure Therapeutics raises USD180m in ADS offering
Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each